Summit Therapeutics, Inc. · 11 hours ago
Director, Real-World Evidence (RWE)
Princeton, NJ
Full-time
Onsite
Director/Executive
$192K/yr - $237K/yr
7+ years expSummit Therapeutics Inc. is a biopharmaceutical oncology company dedicated to improving the quality of life for patients with serious unmet medical needs. They are seeking a Director, Real-World Evidence (RWE) to lead the development and execution of RWE strategies and studies that support access and product differentiation for their investigational therapy, Ivonescimab.
BiotechnologyHealth CareMedical DeviceTherapeutics
Responsibilities
Lead the development and execution of RWE projects to address evidence needs in line with medical affairs, HEOR and market access objectives and business needs
Collaborate internally and externally to address RWE needs and strategies
Formulate research questions, develop study protocols and design robust studies to generate impactful real-world evidence
Conduct annual data gap analyses to identify key areas of evidence generation
Manage project budgets, ensuring efficient resource allocation, vendor management and timely delivery
Ensure data acquisition and transfers follow quality standards coordinating with key stakeholders to ensure data will satisfy analysis plans
Skill and experience identifying, designing and supporting or leading real-world evidence studies
Maintain knowledge and awareness of data sources to identify appropriate data sources for addressing questions of interest, recognizing the limitations and strengths of various design options and sources
Spearhead initiatives of advanced technologies like gen-AI, agentic AI and their applications to RWE
Develop and deliver presentations, manuscripts, scientific data packages or other communications
Assure highest standards of quality, compliance and management of all research activities
Qualification
Required
Advanced degree (Master's, PharmD or PhD) in Epidemiology, Biostatistics, Data Science, Health Outcomes Research, Quantitative Methods, Clinical Informatics or related field
Minimum 7+ years relevant experience in healthcare industry with direct experience in clinical, observational or RWE data management, curation and analysis
Previous experience in Oncology, preferably non-small cell lung cancer (NSCLC)
Demonstrate strong quantitative skills and methods expertise to generate rapid insights from real-world and observational data sources
Experience establishing and maintaining relationships with external vendors and organizations for RWD and RWE
Knowledgeable of the external regulatory environment (FDA, EMA) for real-world evidence and maintains awareness of developments in epidemiology, research, and technology including AI
Experience developing and implementing process and data standards
Demonstrated strong technical writing skills and oral presentation skills with a track-record of publishing in peer-reviewed journals and presenting at medical/scientific conferences
Ability to work under pressure with a high level of autonomy/leadership on research projects and collaborate with multiple partners in a matrixed environment
Preferred
Experience statistical analysis tools such as R and SAS, a plus
Benefits
Bonus
Stock
Benefits
Other applicable variable compensation
Company
Summit Therapeutics, Inc.
Summit Mission Statement: To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, as well as successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs.
201-500 employees
H1B Sponsorship
Summit Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (6)
2023 (1)
Funding
Current Stage
Public CompanyTotal Funding
$1.79BKey Investors
CARB-XEurofarmaBiomedical Advanced Research and Development Authority (BARDA)
2025-10-21Post Ipo Equity· $500M
2024-09-11Post Ipo Equity· $235M
2024-06-03Post Ipo Equity· $200M
Leadership Team
Manmeet Soni
Chief Operating Officer and Board Member
Recent News
The Motley Fool
2026-01-13
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase